Serena Williams has sparked controversy on social media after appearing in a commercial for a weight-loss drug during the Super Bowl.
People often tune into the Super Bowl for different reasons: the game itself, the halftime show, or the highly anticipated commercials.
Super Bowl commercials are expected to be top-notch, with viewers frequently debating which ad stands out each year.
This time, a commercial featuring tennis legend Serena Williams has not been well-received and is unlikely to be remembered as one of the favorites…
In the advertisement, Williams promotes Ro, a GLP-1 drug for weight loss, stating: “It’s not a shortcut. It’s science.”
She continues with: “I’m on Ro, 34 pounds down on GLP-1, healthier on Ro, supported on Ro. FDA approved GLP-1 options, now even in a pill, weight loss expertise I trust.
“I’m moving better on Ro, I’m feeling better on Ro, I am Serena Williams, this is me on Ro.”
The commercial has not been well-received on social media, with many users expressing their concerns on X.
One individual commented: “Serena Williams pushing weight loss drugs…. disgusting.”
Another remarked: “The GLP-1 commercials are absolutely disgusting.
“They target not only obese people but also those with perfectly healthy (looking bodies). That’s why they feature Serena Williams in their Super Bowl ad- to show that even a non-overweight athlete uses the drug.
“Its a vanity drug that promotes unhealthy eating habits with a ‘quick fix’ weight loss injection or pill.”
Another user added: “I thought that was weird. She played professionally for 20 years and now she needs to lose 30? I do not get it.”
Someone else wrote: “It’s pretty damn gross when she could be an advocate for healthy eating. What will she do with all that money? Buy more food that she can’t eat!????”
Additionally, another disappointed user commented: “We are over-medicalizing problems caused by bad food, bad habits, and bad systems. Serena should at best be advertising sneakers, sports shoes than syringes.”
Serena Williams’ representatives have been contacted for comment.